Aaron Mangold

Associate Professor

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Aaron Mangold is an Associate Professor at Mayo Clinic, United States. His research areas include dermatology, particularly focusing on drug repurposing, immune-mediated skin diseases, and the impacts of social media on patient education in melanoma. Recent articles by Professor Mangold examine various therapeutic approaches and patient outcomes in conditions such as necrobiosis lipoidica and pityriasis rubra pilaris.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Pål Johansen

University of Zurich

SWITZERLAND

View details

Mark Pittelkow

Professor and Chair

Mayo Clinic

UNITED STATES

View details

Xing Li

Assistant Professor, Associate Consultant

Mayo Clinic

UNITED STATES

View details

Mark Mellett

University of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Aaron Mangold

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Drug Repurposing Using Molecular Network Analysis Identifies Janus Kinase as Targetable Driver in Necrobiosis Lipoidica

Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States

Targeting IL-1 controls refractory pityriasis rubra pilaris

Social media as a recruitment tactic in melanoma education and protective behaviors in Latino patients

Factors influencing receipt and time to treatment of immunotherapy relative to chemotherapy in stage III and stage IV melanoma

Development of the lichen planus quality of life questionnaire (LPQoL) informed by expert clinician input and patient feedback: a retrospective survey study

Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis

Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination

A rare case of childhood mucous membrane pemphigoid involving the oral and genital mucosa

Survival and Glycemic Control in Patients With co-existing Squamous Cell Carcinoma and Diabetes Mellitus

Collaborators (4)

Pål Johansen

Mark Pittelkow

Xing Li

Mark Mellett

Make your next move.